AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Zuprinor 5 Transdermal Patch

Prescription Icon
Prescription Required

Marketer

Sun Pharmaceutical Industries Ltd

Salt Composition

Buprenorphine (5mg)

Overview Zuprinor 5 Transdermal Patch

Opioid dependence and moderate-to-severe pain are managed with the Zuprinor 5 Transdermal Patch, which also mitigates opioid withdrawal symptoms. Administering the patch requires careful adherence to your physician's instructions for optimal efficacy. Dosage and treatment length are individualized based on your condition and response. Continuous use is crucial; cessation should only occur under medical supervision. Commonly reported side effects include nausea, headache, drowsiness, dizziness, and constipation; these are often more frequent initially or with dosage increases, usually subsiding with continued use. Persistent or severe side effects necessitate patch removal and immediate medical attention. Pre-treatment disclosure of all medical conditions and medications is vital, as interactions with other drugs are possible. Consult your doctor before using Zuprinor 5 if you are pregnant or breastfeeding.

Uses of Zuprinor 5 Transdermal Patch

Morphine addiction; management of significant to intense pain

Major Benefits of Zuprinor 5 Transdermal Patch:

Administer this medication precisely as your physician directs, adhering to both dosage and treatment length. Always verify the product information on the packaging prior to application. Ensure the application area is clean and completely dry. Peel away the patch's protective covering, avoiding contact with the adhesive surface. Apply the patch firmly to the skin with the adhesive side facing downwards, ensuring even contact.

Common Side effects of Zuprinor 5 Transdermal Patch:

  • Headache
  • Back pain
  • Drowsiness
  • Vomiting
  • Insomnia (difficulty in sleeping)
  • Dizziness
  • Abdominal pain
  • Weakness
  • Sweating
  • Constipation
  • Withdrawal syndrome
  • Infection
  • Vertigo
  • Inflammation of the nose
  • Chills
  • Flu-like symptoms
  • Nausea

How to use Zuprinor 5 Transdermal Patch:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always verify the product information before application. Ensure the application area is clean and completely dry. Peel away the patch's protective backing. Avoid contact with the adhesive surface. Apply the patch firmly to the skin, adhesive side down, ensuring even contact.

How Zuprinor 5 Transdermal Patch works:

The transdermal Zuprinor 5 patch utilizes a partial opioid agonist mechanism. This medication mitigates opioid withdrawal symptoms by mimicking the effects of opioid drugs. Simultaneously, it alleviates pain by interacting with specialized brain receptors, thereby modifying pain perception and response.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zuprinor 5 Transdermal Patches during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The transdermal administration of Zuprinor 5 may pose a risk to breastfeeding infants. Available human data indicates potential transfer of the medication into breast milk, with the possibility of adverse effects on the nursing child.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, the use of Zuprinor 5 Transdermal Patches requires careful monitoring. Dosage modification of Zuprinor 5 Transdermal Patches might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

The transdermal Zuprinor 5 patch requires careful administration in individuals with advanced liver dysfunction. Dosage modification of the Zuprinor 5 patch may be necessary. Physician consultation is recommended. An alternative pain reliever offering greater dosing flexibility might be preferable for patients exhibiting significant hepatic compromise.

What if you forget to take Zuprinor 5 Transdermal Patch :

NA

Facts to Know About Zuprinor 5 Transdermal Patch

LabelValue
Chemical Category Phenanthrene Derivatives
Developing Habits .
Type of Therapy Neuroscience Central Nervous System

FAQs on Zuprinor 5 Transdermal Patch

Zuprinor 5 Transdermal Patches treat severe pain inadequately managed or not tolerated with other medications. This isn't for minor or intermittent pain, or for pain relief on an as-needed basis. It also treats opioid use disorder.
Apply the Zuprinor 5 Transdermal Patch to clean, dry, rash-free skin with minimal hair on the upper chest, back, or side. Use only water to cleanse the application site; avoid soaps, oils, or gels. Dispose of used patches safely and away from children and pets. Skin varies; follow your doctor's placement instructions.
Use only undamaged skin patches. Apply only one patch at a time, unless otherwise directed by your doctor. Avoid applying the patch to irritated or damaged skin. Keep the patch out of a child's reach. Don't let children watch you apply the patch, and never refer to it as a bandage.
To prevent overdose and potential death, avoid heat exposure while wearing the patch. This includes heating pads, electric blankets, tanning beds, saunas, direct sunlight, hot baths, and strenuous exercise. Heat accelerates medicine absorption through the skin.
Avoid layering patches; each patch must adhere directly to your skin. Always consult your doctor if you have any questions about using this medication.
Should you have difficulty applying the patch, avoid using bandages or tape. Consult your doctor or pharmacist.
Showering and swimming are permitted while using the Zuprinor 5 Transdermal Patch, but keep immersion brief. Always check the patch's adherence afterward and thoroughly dry the surrounding skin. If the patch falls off, apply a new one to a different area and return the old patch to its original packaging. Follow your doctor's instructions for use.
This medication can significantly lower your blood pressure, potentially causing dizziness when standing up, particularly if you're also taking anti-hypertensive drugs. Consult your doctor, who may adjust your dosage.
Get immediate medical attention if you experience shallow breathing, chest pain, rapid heart rate, seizures, dizziness (feeling faint), blisters, swelling, or severe skin irritation at the patch site, nausea, vomiting, appetite loss, or liver issues such as upper abdominal pain, dark urine, pale stools, or jaundice (yellowing of skin or eyes).
Using Zuprinor 5 Transdermal Patches during pregnancy may lead to your baby's dependence on the medication, potentially resulting in life-threatening withdrawal symptoms after birth. Newborns experiencing this withdrawal may require several weeks of medical care.
Zuprinor 5 Transdermal Patches may transfer into breast milk, potentially causing respiratory distress or even life-threatening complications in nursing infants. Consult your doctor thoroughly regarding the associated risks.
Store Zuprinor 5 Transdermal Patches at room temperature, away from heat, moisture, and sunlight, in a secure place inaccessible to children. Dispose of any unused portions properly.
Zuprinor 5 Transdermal Patch, an opioid partial agonist-antagonist, provides pain relief. As a controlled substance with addictive potential, alternative pain management should be discussed with your doctor if addiction occurs.
Zuprinor 5 Transdermal Patches inhibit the effects of opiates.
Zuprinor 5 Transdermal Patch is not associated with depression. Report any depressive symptoms to your doctor.
Zuprinor 5 Transdermal Pa...
518
MRP 599
13% off